Grindeks
| Use attributes for filter ! | |
| Revenue | 132. 4 million EUR (2017) |
|---|---|
| Number of employees | 1,355 (2017) |
| Headquarters | Riga |
| Latvia | |
| Founded | October 11 |
| 1991 | |
| Net income | 10. 3 million EUR (2017) |
| Type of business | Publicly listed company |
| Date of Reg. | |
| Date of Upd. | |
| ID | 1094963 |
About Grindeks
AS Grindeks, is a Latvian company listed on the Nasdaq Riga with production of pharmaceutical drugs, medicine and phytochemical medicine. The company was founded 17 October 1991 and is a joint stock company since 25 August 1997. One of the key drugs for Grindeks is meldonium, marketed under the trade name Mildronate.
